Stroke and Vascular Neurology (Sep 2020)
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population
- Anding Xu,
- Yongjun Wang,
- Yilong Wang,
- Yuan Gao,
- Wei Liu,
- Qiang Dong,
- Zixiao Li,
- Xingquan Zhao,
- Bin Jiang,
- Yong Jiang,
- Wenzhi Wang,
- Yapeng Li,
- Xiaomeng Yang,
- Tingting Wang,
- Li He Li Guo,
- Bo Hu,
- Tielin Li,
- Chaodong Zhang,
- Gang Zhao,
- Dongling Sun,
- Haixin Sun,
- Xiaojuan Ru,
- Penglian Wang,
- Lixia Zong,
- Yuyuan Xu,
- Dingfeng Su,
- Haiqiang Qin,
- Lei Guo,
- Huaguang Zheng,
- Shangrong Han,
- Yong Cao,
- Ling Guan,
- Qian Jia,
- Yuming Jiao,
- Shuya Li,
- Xuewei Xie,
- Yingying Yang,
- Mengyuan Zhou
Affiliations
- Anding Xu
- 5 Department of Neurology, The First Affiliated Hospital, Jinan University Guangzhou, Guangzhou, Guangdong, China
- Yongjun Wang
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yilong Wang
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yuan Gao
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Wei Liu
- 2 Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore
- Qiang Dong
- 6 Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China
- Zixiao Li
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Xingquan Zhao
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Bin Jiang
- Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences, Beijing, China
- Yong Jiang
- Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
- Wenzhi Wang
- Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
- Yapeng Li
- 6 Neurology, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China
- Xiaomeng Yang
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Tingting Wang
- Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China
- Li He Li Guo
- Bo Hu
- 1 Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- Tielin Li
- Chaodong Zhang
- Gang Zhao
- Dongling Sun
- Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
- Haixin Sun
- Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
- Xiaojuan Ru
- Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
- Penglian Wang
- professor
- Lixia Zong
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yuyuan Xu
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Dingfeng Su
- Haiqiang Qin
- Department of Neurology, Beijing Tiantian Hospital, Capital Medical University, Beijing, China
- Lei Guo
- 1 Department of Clinical Psychology, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Huaguang Zheng
- professor
- Shangrong Han
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yong Cao
- 1 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Ling Guan
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Qian Jia
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yuming Jiao
- 1 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Shuya Li
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Xuewei Xie
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yingying Yang
- Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China
- Mengyuan Zhou
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- DOI
- https://doi.org/10.1136/svn-2020-000385
- Journal volume & issue
-
Vol. 5,
no. 3
Abstract
Aim Cerebrovascular disease is the leading cause of death and disability in China, causing a huge burden among patients and their families. Hence, stroke prevention is critical, especially in the high-risk population. Here, we present the evidence-based guideline suitable for the Chinese population.Methods Literature search of PubMed and Cochrane library (from January 1964 to June 2019) was done. After thorough discussion among the writing group members, recommendations were listed and summarised. This guideline was reviewed and discussed by the fellow writing committees of the Chinese Stroke Association’s Stroke.Results This evidence-based guideline was written in three parts: controlling the risk factors of stroke, utilisation of antiplatelet agents and assessing the risks of first-ever stroke. All recommendations were listed along with the recommending classes and levels of evidence.Conclusions This guideline provides recommendations for primary prevention of cerebrovascular disease among high-risk population in China. Controlling related risk factors, appropriately using antiplatelet agents, assessing the risk of developing first-ever stroke should help reduce the rate of cerebrovascular disease in China.
